Back to Preventive Services Home Page

Colorectal Cancer Screening (NCD 210.3)

Medicare covers colorectal cancer screening tests to help find pre-cancerous polyps (growths in the colon), so polyps can be removed before they become cancerous and to help find colorectal cancer at an early stage when treatment works best.

Expanded Coverage! Medicare began covering the Cologuard™ Multitarget Stool DNA (sDNA) Test effective October 9, 2014.

Effective January 1, 2016, use CPT code 81528 when billing for the Cologuard™ test (note that your MAC will accept HCPCS code G0464 for claims with dates of service on or before December 31, 2015).

Only laboratories authorized by the manufacturer to perform the Cologuard test may bill for this test.

HCPCS/CPT Codes


00810 – Anesthesia for lower intestinal endoscopic procedures, endoscope introduced distal to duodenum

00812 – Anesthesia for lower intestinal endoscopic procedures, endoscope introduced distal to duodenum; screening colonoscopy

81528 – Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result

82270 – Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)

G0104 – Flexible Sigmoidoscopy

G0105 – Colonoscopy (high risk)

G0106 – Barium Enema (alternative to G0104)

G0120 – Barium Enema (alternative to G0105)

G0121 – Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk

G0328 – Fecal Occult Blood Test (FOBT), immunoassay, 1-3 simultaneous

G0464 – Colorectal cancer screening; stool-based DNA and fecal occult hemoglobin (e.g., KRAS, NDRG4 and BMP3)

ICD-10-CM (ICD-9-CM) Codes


No specific diagnosis code

Contact local Medicare Administrative Contractor (MAC) for guidance

For Cologuard Multitarget Stool DNA (sDNA) Test, use Z12.11 and Z12.12

Who Is Covered


For colorectal cancer screening using Cologuard™—a Multitarget Stool DNA (sDNA) Test:

All Medicare beneficiaries:

  • Aged 50 to 85 years;
  • Asymptomatic; and
  • At average risk of developing colorectal cancer, meaning they have no personal history of adenomatous polyps, colorectal cancer, or inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis.

For screening colonoscopies, FOBTs, flexible sigmoidoscopies, and barium enemas:

All Medicare beneficiaries:

  • Aged 50 and older who are at normal risk of developing colorectal cancer; or
  • At high risk of developing colorectal cancer

“High risk for developing colorectal cancer” is defined in the Code of Federal Regulations (CFR) at 42 CFR 410.37(a)(3).

NOTE: For coverage of screening colonoscopies, there is no age limitation.

Frequency


Normal Risk:

  • Cologuard™ Multitarget Stool DNA (sDNA) Test: once every 3 years;
  • Screening FOBT: every year;
  • Screening flexible sigmoidoscopy: once every 4 years (unless a screening colonoscopy has been performed and then Medicare may cover a screening flexible sigmoidoscopy only after at least 119 months);
  • Screening colonoscopy: every 10 years (unless a screening flexible sigmoidoscopy has been performed and then Medicare may cover a screening colonoscopy only after 47 months); and
  • Screening barium enema (as an alternative to covered screening flexible sigmoidoscopy)

High Risk:

  • Screening FOBT: every year;
  • Screening flexible sigmoidoscopy: once every 4 years;
  • Screening colonoscopy: every 2 years (unless a screening flexible sigmoidoscopy has been performed and then Medicare may cover a screening colonoscopy only after at least 47 months); and
  • Screening barium enema (as an alternative to covered screening flexible sigmoidoscopy or colonoscopy)

Beneficiary Pays


You pay nothing for the fecal occult blood test, if you get a written referral from your doctor, physician assistant, nurse practitioner, or clinical nurse specialist. You pay nothing for the flexible sigmoidoscopy or screening colonoscopy if your doctor accepts assignment.

Note: If a polyp or other tissue is found and removed during the colonoscopy, you may have to pay 20% of the Medicare-approved amount for the doctor’s services and a copayment in a hospital outpatient setting.

For barium enemas, you pay 20% of the Medicare-approved amount for the doctor’s services. The Part B deductible doesn’t apply. If it’s done in a hospital outpatient setting, you pay a copayment.

81528, 82270, G0104, G0105, G0121, and G0328, and G0464:

  • Copayment/coinsurance waived
  • Deductible waived

Append modifier - 33 to the anesthesia CPT code 00810 when you furnish a separately payable anesthesia service in conjunction with a screening colonoscopy (G0105 and G0121) to waive beneficiary copayment/coinsurance and deductible.

G0106 and G0120:

  • Copayment/coinsurance waived
  • Deductible waived

No deductible for all surgical procedures (CPT code range of 10000 to 69999) furnished on the same date and in the same encounter as a screening colonoscopy, flexible sigmoidoscopy, or barium enema initiated as colorectal cancer screening services.

Append modifier - PT to CPT code in the surgical range of 10000 to 69999 in this scenario.

Frequently Asked Questions (FAQs)


Am I at high risk for colorectal cancer?

Risk for colorectal cancer increases with age. It’s important to continue with screenings, even if you were screened before you had Medicare. Your risk for colorectal cancer increases if any of these are true:

  • You’ve had colorectal cancer before.
  • You have a close relative who had colorectal polyps or colorectal cancer.
  • You have a history of polyps.
  • You have inflammatory bowel disease (like ulcerative colitis or Crohn’s disease).

5 ways you can prevent colorectal cancer?

Did you know that colorectal cancer is the second leading cause of cancer death among men and women in the United States? Make sure you’re doing everything you can to prevent it, including getting help from Medicare. Colorectal cancer affects people in all racial and ethnic groups and is most often found in people age 50 and older. It’s National Colorectal Cancer Awareness Month, so this is a great time to do 5 things to stop this cancer in its tracks.

  • Get screened.
  • Exercise.
  • Maintain a healthy weight.
  • Don’t drink too much alcohol.
  • Don’t smoke.

Other Notes


  • Effective January 1, 2016, CPT code 81528 replaced HCPCS G0464 for the Cologuard™ multitarget stool DNA (sDNA) test. Refer to National Coverage Determination (NCD) for Screening for Colorectal Cancer Using Cologuard™—A Multitarget Stool DNA Test MLN Matters Article® MM9115 for more information.
  • Append modifier –33 (Preventive Service) to the anesthesia CPT code 00812 when you furnish a separately payable anesthesia service in conjunction with a screening colonoscopy (G0105 and G0121) to waive Medicare beneficiary copayment/coinsurance and deductible.
  • Effective January 1, 2018, when a screening colonoscopy becomes a diagnostic colonoscopy, report anesthesia services with CPT code 00811 (Anesthesia for lower intestinal endoscopic procedures, endoscope introduced distal to duodenum; not otherwise specified) with only the –PT modifier, and only the deductible will be waived. Report this in addition to 00812.
  • CPT code 00810 end date is December 31, 2017.
  • Coinsurance and deductible are waived for moderate sedation services (reported with G0500 or 99153) when furnished in conjunction with and in support of a screening colonoscopy service and when reported with modifier –33. When a screening colonoscopy becomes a diagnostic colonoscopy, moderate sedation services (G0500 or 99153) are reported with only the –PT modifier; only the deductible is waived.

Back to Preventive Services Home Page